Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Pacis

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
EMBO Reports|January 28, 2026
EZH2 directs HER2+ breast cancer progression through the modulation of epithelial plasticityLinshan Liu, Ellie J Massey, Dongmei Zuo, et al.
Gastroenterology|October 18, 2019
Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21Cezary Ciszewski, Valentina Discepolo, Alain Pacis, et al.
The Journal of Clinical Investigation|September 2, 2021
Alveolar macrophages from persons living with HIV show impaired epigenetic response to Mycobacterium tuberculosisWilian Correa-Macedo, Vinicius M Fava, Marianna Orlova, et al.
Nature Communications|February 19, 2021
Non-CG methylation and multiple histone profiles associate child abuse with immune and small GTPase dysregulationPierre-Eric Lutz, Marc-Aurèle Chay, Alain Pacis, et al.
Cancer Research|May 15, 2025
Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis InitiationIslam E Elkholi, Amélie Robert, Camille Malouf, et al.
Cell|October 22, 2016
Genetic Ancestry and Natural Selection Drive Population Differences in Immune Responses to PathogensYohann Nédélec, Joaquín Sanz, Golshid Baharian, et al.
NPJ Precision Oncology|August 9, 2023
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancersJoan Miguel Romero, Emma Titmuss, Yifan Wang, et al.
Nature Communications|October 25, 2024
Osteopontin is a therapeutic target that drives breast cancer recurrenceYu Gu, Tarek Taifour, Tung Bui, et al.
Cell|January 13, 2018
BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against TuberculosisEva Kaufmann, Joaquin Sanz, Jonathan L Dunn, et al.
The Journal of Clinical Investigation|February 16, 2023
Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progressionIpshita Nandi, Harvey W Smith, Virginie Sanguin-Gendreau, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
EMBO Reports|January 28, 2026
EZH2 directs HER2+ breast cancer progression through the modulation of epithelial plasticityLinshan Liu, Ellie J Massey, Dongmei Zuo, et al.
Gastroenterology|October 18, 2019
Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21Cezary Ciszewski, Valentina Discepolo, Alain Pacis, et al.
The Journal of Clinical Investigation|September 2, 2021
Alveolar macrophages from persons living with HIV show impaired epigenetic response to Mycobacterium tuberculosisWilian Correa-Macedo, Vinicius M Fava, Marianna Orlova, et al.
Nature Communications|February 19, 2021
Non-CG methylation and multiple histone profiles associate child abuse with immune and small GTPase dysregulationPierre-Eric Lutz, Marc-Aurèle Chay, Alain Pacis, et al.
Cancer Research|May 15, 2025
Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis InitiationIslam E Elkholi, Amélie Robert, Camille Malouf, et al.
Cell|October 22, 2016
Genetic Ancestry and Natural Selection Drive Population Differences in Immune Responses to PathogensYohann Nédélec, Joaquín Sanz, Golshid Baharian, et al.
NPJ Precision Oncology|August 9, 2023
Chemokine expression predicts T cell-inflammation and improved survival with checkpoint inhibition across solid cancersJoan Miguel Romero, Emma Titmuss, Yifan Wang, et al.
Nature Communications|October 25, 2024
Osteopontin is a therapeutic target that drives breast cancer recurrenceYu Gu, Tarek Taifour, Tung Bui, et al.
Cell|January 13, 2018
BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against TuberculosisEva Kaufmann, Joaquin Sanz, Jonathan L Dunn, et al.
The Journal of Clinical Investigation|February 16, 2023
Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progressionIpshita Nandi, Harvey W Smith, Virginie Sanguin-Gendreau, et al.
Pageof 5